|
84
|
273
|
4f4pA |
Syk in complex with ligand lasw836 |
|
75
|
276
|
4f1oA |
Crystal structure of the l1180t mutant roco4 kinase domain from d. discoideum bound to appcp |
|
90
|
297
|
4qqtA |
Crystal structure of fgf receptor (fgfr) 4 tyrosine kinase domain |
|
87
|
302
|
4f65A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with compound 8 |
|
88
|
299
|
4f64A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with compound 6 |
|
77
|
278
|
4f1mA |
Crystal structure of the g1179s roco4 kinase domain bound to appcp from d. discoideum. |
|
68
|
276
|
4f1tA |
Crystal structure of the roco4 kinase domain from d. discoideum bound to the rock inhibitor h1152 |
|
94
|
303
|
4hw7A |
Crystal structure of fms kinase domain with a small molecular inhibitor, plx647-ome |
|
91
|
290
|
4f09A |
Discovery and optimization of c-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable jak1 inhibitors with selectivity over jak2 |
|
88
|
289
|
4hvhA |
Jak3 kinase domain in complex with 2-cyclopropyl-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((r)-2-hydroxy-1,2-dimethyl-propyl |
|
83
|
287
|
4hvdA |
Jak3 kinase domain in complex with 2-cyclopropyl-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((s)-1,2,2-trimethyl-propyl)-amide |
|
104
|
326
|
4hvsA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx647 |
|
81
|
277
|
4f0gA |
Crystal structure of the roco4 kinase domain from d. discoideum |
|
78
|
275
|
4ewhA |
Co-crystal structure of ack1 with inhibitor |
|
91
|
291
|
4pmpA |
The structure of trka kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-[4-(trifluoromethoxy)phenyl]urea |
|
107
|
377
|
4e93A |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes)in complex with tae684 |
|
92
|
290
|
4e4lA |
Jak1 kinase (jh1 domain) in complex with compound 30 |
|
87
|
291
|
4e1zA |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
86
|
297
|
4ehzA |
The jak1 kinase domain in complex with inhibitor |
|
93
|
298
|
4e4mA |
Jak2 kinase (jh1 domain) in complex with compound 30 |
|
96
|
298
|
4e6qA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 12 |
|
88
|
277
|
4ebvA |
Structure of focal adhesion kinase catalytic domain in complex with novel allosteric inhibitor |
|
88
|
290
|
4e20A |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
101
|
293
|
4e6dA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 7 |
|
84
|
302
|
4ei4A |
Jak1 kinase (jh1 domain) in complex with compound 20 |
|
81
|
276
|
4ebwA |
Structure of focal adhesion kinase catalytic domain in complex with novel allosteric inhibitor |
|
76
|
276
|
4e26A |
Braf in complex with an organic inhibitor 7898734 |
|
73
|
276
|
4ehgA |
B-raf kinase domain in complex with an aminopyridimine-based inhibitor |
|
89
|
302
|
4e4nA |
Jak1 kinase (jh1 domain) in complex with compound 49 |
|
93
|
293
|
4dymA |
Crystal structure of the acvr1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor k00135 |
|
72
|
276
|
4eheA |
B-raf kinase domain in complex with an aminothienopyrimidine-based inhibitor |
|
69
|
274
|
4e4xA |
Crystal structure of b-raf kinase domain in complex with a dihydropyrido[2,3-d]pyrimidinone-based inhibitor |
|
84
|
302
|
4eevA |
Crystal structure of c-met in complex with ly2801653 |
|
91
|
302
|
4e5wA |
Jak1 kinase (jh1 domain) in complex with compound 26 |
|
87
|
294
|
4deiA |
Crystal structure of c-met in complex with triazolopyridinone inhibitor 24 |
|
81
|
272
|
4d4yA |
Focal adhesion kinase catalytic domain |
|
92
|
308
|
4ctcA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 7-amino-3-cyclopropyl-12-fluoro-1,10,16-trimethyl-16,17- dihydro-1h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecin-15(10h)-one |
|
103
|
292
|
4d0wA |
Pyrrole-3-carboxamides as potent and selective jak2 inhibitors |
|
94
|
289
|
4d1sA |
Pyrrole-3-carboxamides as potent and selective jak2 inhibitors |
|
87
|
294
|
4dehA |
Crystal structure of c-met in complex with triazolopyridinone inhibitor 3 |
|
83
|
272
|
4d4rA |
Focal adhesion kinase catalytic domain |
|
79
|
272
|
4d5hA |
Focal adhesion kinase catalytic domain |
|
98
|
309
|
4ctbA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor (5r)-8-amino-3-fluoro-5,19-dimethyl-20-oxo-5,18,19,20- tetrahydro-7,11-(azeno)pyrido(2',1':2,3)imidazo(4,5-h)(2,5,11) benzoxadiazacyclotetradecine-14-carbonitrile |
|
86
|
272
|
4d5kA |
Focal adhesion kinase catalytic domain |
|
81
|
273
|
4d58A |
Focal adhesion kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor |
|
98
|
293
|
4d0xA |
Pyrrole-3-carboxamides as potent and selective jak2 inhibitors |
|
82
|
273
|
4d55A |
Focal adhesion kinase catalytic domain |
|
82
|
278
|
4dggA |
C-src kinase domain in complex with rm-1-176 |
|
79
|
272
|
4d4sA |
Focal adhesion kinase catalytic domain |
|
83
|
274
|
4dfnA |
Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor |
